Autoimmune hepatitis

New England Journal of Medicine

Volumn 334, Issue 14, 1996, Pages 897-903

  Krawitt, Edward L ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS; HUMAN; IMMUNOLOGY; LIVER; MALE; PATHOLOGY; REVIEW; AUTOIMMUNE HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS; HUMANS; LIVER; MALE;

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

EID: 0030568394     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199604043341406     Document Type: Review

References (79)

1. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
2. Sanchez-Urdazpal LS, Czaja AJ, van Hoek B, Krom RAF, Wiesner RH. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis Hepatology 1992,15:215-21.
3. Knox TA, Kaplan MM. Primary biliary cirrhosis: clinical presentation and natural history. In: Krawitt EL, Wiesner RH, eds. Autoimmune liver diseases. New York: Raven Press, 1991:167-73.
4. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 1995;90:247-9.
5. Lee Y-M, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332:924-33.
6. Lunel F, Abuaf N, Frangeul L, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-6.
7. Clifford BD, Donahue D, Smith L, et al High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-9.
8. Reddy KR, Krawitt EL, Homberg J-C, et al. Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America. J Viral Hepatitis 1995;2:175-9
9. Batts KP, Ludwig J. Histopathology of autoimmune chronic active hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, eds. Autoimmune liver diseases. New York. Raven Press, 1991.75-92
10. Lashner BA, Jonas RB, Tang H-S, Evans AA, Ozeran SE, Baker AL. Chronic hepatitis: disease factors at diagnosis predictive of mortality. Am J Med 1988;85:609-14.
11. Davis PA, Leung P, Manns M, et al. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? Hepatology 1992;16:1128-36
12. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis Hepatology 1993;18. 10-5.
13. Gordon SC, Quattrociocchi-Longe TM, Khan BA, et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 1995;108:1802-9.
14. Mackay IR, Morris PJ. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet 1972;2:793-5.
15. Krawitt EL, Albertini RJ Immunogenetica of autoimmune chronic active hepatitis. In. Meyer zum Büschenfelde K-H, Hoofnagle JH, Manns M, eds. Immunology and liver. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1993:240-9.
16. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701-6.
17. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type I autoimmune hepatitis. Gastroenterology 1993;105:1502-7.
18. Doherty DG, Donaldson PT, Underhill JA, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994;19:609-15.
19. Manabe K, Hibberd ML, Donaldson PT, et al. T-cell receptor constant β germline gene polymorphisms and susceptibility to autoimmune hepatitis. Gastroenterology 1994;106:1321-5.
20. Krawitt EL, Kilby AE, Albertini RJ, et al. Immunogenetic studies of autoimmune chronic active hepatitis: HLA, immunoglobulin allotypes and autoantibodies. Hepatology 1987;7:1305-10.
21. Robertson DAF, Zhang SL, Guy EC, Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis Lancet 1987,2.9-11.
22. Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991;337:1183-7.
23. Rahaman SM, Chira P, Koff RS. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol 1994;89 106-8.
24. Cianciara J, Laskus T Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B. Dig Dis Sci 1995,40:1842-4.
25. García-Buey L, García-Monzón C, Rodriguez S, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995;108:1770-7.
26. Bellary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C. favorable response to prednisone and azathioprine. Ann Intern Med 1995; 123:32-4.
27. Vento S, Guella L, Mirandola F, et al Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995,346:608-9.
28. Meyer zum Büschenfelde K-H, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. Hepatology 1990;12:354-63
29. Wen L, Peakman M, Lobo-Yeo A, et al. T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis Lancet 1990;336:1527-30
30. Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde K-H Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol 1992;88:45-9.
31. Lohse AW, Kögel M, Meyer zum Büschenfelde K-H Evidence for spontaneous immunosuppression in autoimmune hepatitis Hepatology 1995;22: 381-8
32. Treichel U, McFarlane BM, Seki T, et al Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 1994;107:799-804
33. Nouri-Aria KT, Hegarty JE, Alexander GJM, Eddleston ALWF, Williams R. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis. N Engl J Med 1982;307:1301-4.
34. Abauf N, Johanet C, Homberg J-C Autoantibodies in autoimmune chronic active hepatitis. In: Krawitt EL, Wiesner RH, eds. Autoimmune liver diseases. New York: Raven Press, 1991:93-109.
35. Homberg J-C, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis Hepatology 1987;7:1333-9
36. Martini E, Abnaf N, Caralli F, Durand V, Johanet C, Homberg J-C. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662-6.
37. Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology 1992;16:892-8.
38. Han S, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 1995;21:58-62.
39. Duclos-Vallée J-C, Hajoui O, Yamamoto AM, Jacz-Aigrain E, Alvarez F. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies. Gastroenterology 1995,108:470-6.
40. Philipp T, Durazzo M, Trautwein C, et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet 1994;344:578-81.
41. Manns M, Gerken G, Kyriatsoulis A, Stantz M, Meyer zum Büschenfelde K-H. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987,1: 292-4.
42. Wächter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Buschenfelde K-H, Manns M. Characterisation of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol 1990;11:232-9.
43. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993;105:1522-8.
44. Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995;90:1206-11.
45. Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 1993;18:1-9.
46. Toda G, Ikeda Y, Kashiwagi M, Iwamori M, Oka H. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide. Hepatology 1990,12 664-70.
47. Wesierska-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamins in autoimmune liver disease. Clin Immunol Immunopathol 1988;49:107-15.
48. Worman HJ, Courvalin J-C. Autoantibodies against nuclear envelope proteins in liver disease Hepatology 1991;14:1269-79.
49. Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis Am J Clin Pathol 1993,99:277-81.
50. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993;17:411-7.
51. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995; 108:1159-66.
52. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993;104:1755-61.
53. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990;335:754-7.
54. Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde K-H, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992,339.267-9
55. Mishiro S, Hoshi Y, Takeda K, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope. implication for an autoimmune process. Lancet 1990;336:1400-3. [Erratum, Lancet 1990;337 252.]
56. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294-7.
57. Bianchi FB. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus. J Hepatol 1993;18:273-5.
58. Zeniya M, Aizawa Y, Watanabe F, et al. HCV-marker-positive autoimmune-type chronic active hepatitis: a possible relation between HCV infection and liver autoreaction. Liver 1994;14:206-12
59. Roitt IM. Essential immunology. 8th ed. Oxford, England: Blackwell Scientific, 1994:384.
60. Perdigoto R, Carpenter HA, Czaja AJ Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis J Hepatol 1992;14:325-31.
61. Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology 1988;8:1679-83.
62. Tage-Jensen U, Schlichting P, Thomson HF, Høybye G, Thomson AC. Malignancies following long-term azathioprine treatment in chronic liver disease: a report from the Copenhagen Study Group for Liver Diseases. Liver 1987;7:81-3
63. Ryder SD, Koskinas J, Rizzi PM, et al. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus. Hepatology 1995;22:718-22.
64. Wang KK, Czaja AJ, Beaver SJ, Go VLW. Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Hepatology 1989;10:39-43.
65. Czaja AJ. Treatment of autoimmune hepatitis. In: Nishioka M, Toda G, Zeniya M, eds. Autoimmune hepatitis. Amsterdam: Elsevier, 1994:283-304.
66. Kuroki T, Monna T, Yamamoto S. Treatment of autoimmune hepatitis in Japan In Nishioka M, Toda G, Zeniya M, eds. Autoimmune hepatitis. Amsterdam: Elsevier, 1994:305-16.
67. Stellon AJ, Keating JJ, Johnson PJ, McFarlane IG, Williams R. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology 1988,8:781-4.
68. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333.958-63.
69. Czaja AJ, Wang KK, Shiels MT, Katzmann JA. Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis: a prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses. J Hepatol 1993;17:180-6.
70. Czaja AJ. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis. Hepatology 1990;11:1044-9.
71. Devlin J, Donaldson P, Portmann B, Heaton N, Tan K-C, Williams R. Recurrence of autoimmune hepatitis following liver transplantation. Liver Transplant Surg 1995;1.162-5.
72. Mistilis SP, Vickers CR, Darroch MH, McCarthy SW. Cyclosporine, a new treatment for autoimmune chronic active hepatitis. Med J Aust 1985;143: 463-5.
73. Hyams JS, Ballow M, Leichtner AM. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology 1987;93:890-3.
74. Sherman KE, Narkewicz M, Pinto PC. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. J Hepatol 1994;21:1040-7.
75. Van Thiel DH, Wright H, Carroll P, et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995;90:771-6.
76. Ratziu V, Samuel D, Farges O, et al. Liver transplantation (LT) for autoimmune cirrhosis (AIC): evidence of recurrence of primary disease on the engrafted liver. Hepatology 1994;20 Suppl:120A. abstract.
77. Neuberger J, Portmann B, Calne R, Williams R. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 1984;37:363-5
78. Wright HL, Bou-Abboud CF, Hassanein T, et al. Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 1992;53:136-9.
79. Roberts S, Czaja AJ, Charlton MR, et al. Recurrent autoimmune hepatitis following orthotopic liver transplantation. Hepatology 1995,22:Suppl:215A. abstract.